Life Sciences 2017 - Chemical BiologyLS17-029

bac-PROTAC: Developing proteolysis-targeting small molecules for the selective elimination of bacterial proteins


Principal Investigator:
Collaborators:
Markus Hartl (University of Vienna) (Co-Principal Investigator)
Markus Kaiser (Unviersity of Duisburg-Essen) (Co-Principal Investigator)
Status:
Ongoing (01.06.2018 – 31.05.2022)
Funding volume:
€ 700,000

 
Abstract:

The AAA protease ClpCP constitutes the core of the protein quality control system in Gram-positive bacteria, removing damaged proteins during stress situations. Aberrant proteins that need to be degraded are labeled by McsB, a protein kinase unique in phosphorylating arginine residues. The resulting pArg degradation mark is recognized by the N-terminal domain (NTD) of the ClpC unfoldase, which then translocates the captured client protein into the proteolytic cage formed by ClpP. The described pArg-ClpCP degradation system represents a simple, bacterial version of the eukaryotic ubiquitin-proteasome pathway. In this project, we will pursue a Chemical Biology approach to address the unique mechanistic features of the ClpCP protease. Guided by the structure of the recognized pArg mark, we will synthesize chemical substrate-mimics of ClpCP and characterize their binding mode by biochemical, mass spectrometric and crystallographic studies. Elucidating structural details of the pArg-dependent targeting mechanism holds great potential for developing a bac-PROTAC methodology that would allow for targeted, small molecule-induced protein degradation in bacteria. This system may be employed in basic microbial research as well as an alternative chemotherapeutic strategy against pathogenic bacteria, which still represent a major threat to human health.

 

We use cookies on our website. Some of them are technically necessary, while others help us to improve this website or provide additional functionalities. Further information